Therapeutics Acquisition Corp.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Therapeutics Acquisition Corp.
CIK #0001811764
EDGAR Form CIK 2011 - 2024
10-K [0001811764]
10-Q [0001811764]
3 [0001811764]
4 [0001811764]
5 [0001811764]
8-K [0001811764]
SC 13D [0001811764]
SC 13G [0001811764]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Point Biopharma Global Inc [2023-02-03]
Biotechnology Value Fund L P Point Biopharma Global Inc [2022-09-26]
RA Capital Management LP Point Biopharma Global Inc [2021-07-20]
Silber Allan C Point Biopharma Global Inc [2021-07-12]
RA Capital Management LP Therapeutics Acquisition Corp [2021-06-30]
Riverview Group LLC Therapeutics Acquisition Corp [2021-05-10]
Suvretta Capital Management LLC Therapeutics Acquisition Corp [2021-04-02]
Price T Rowe Associates Inc /MD/ Therapeutics Acquisition Corp [2021-02-16]
Perceptive Advisors LLC Therapeutics Acquisition Corp [2021-02-16]
Avoro Capital Advisors LLC Therapeutics Acquisition Corp [2021-02-12]
View All
Form 3/4/5 Subject 2011 - 2024
Martell Bridget A
POINT Biopharma Global Inc.
Malik Rajesh
Lubner David Charles
Hogue Gerald L
Goodman Jonathan R
Margolin Yael
Fleshner Neil E
Jensen Jessica D
Demers William L
View All
Terms | Privacy | Guide
tony@aum13f.com